{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:22:47Z","timestamp":1794208967973,"version":"4.8.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA009523"],"award-info":[{"award-number":["T32CA009523"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01 CA265762"],"award-info":[{"award-number":["P01 CA265762"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32CA275782"],"award-info":[{"award-number":["T32CA275782"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.slasd.2026.100339","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:13:46Z","timestamp":1789722826000},"page":"100339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Patient-derived 3d cell models as new approach methodologies: Applications, advances, and challenges for increased-throughput assays"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2729-4147","authenticated-orcid":false,"given":"Asimina S.","family":"Courelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6244-4958","authenticated-orcid":false,"given":"Mia","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5039-6750","authenticated-orcid":false,"given":"Herv\u00e9","family":"Tiriac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.slasd.2026.100339_bib0001","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10627","article-title":"Advances in high throughput cell culture technologies for therapeutic screening and biological discovery applications","volume":"9","author":"Ryoo","year":"2024","journal-title":"Bioeng Transl Med"},{"issue":"3","key":"10.1016\/j.slasd.2026.100339_bib0002","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.slasd.2022.03.006","article-title":"SLAS special issue editorial 2022: 3D cell culture approaches of microphysiologically relevant models","volume":"27","author":"Souza","year":"2022","journal-title":"SLAS Discov"},{"issue":"5","key":"10.1016\/j.slasd.2026.100339_bib0003","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/2472555217702448","article-title":"Three-dimensional cell culture: a rapidly emerging approach to cellular science and drug discovery","volume":"22","author":"Eglen","year":"2017","journal-title":"SLAS Discov"},{"issue":"7","key":"10.1016\/j.slasd.2026.100339_bib0004","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s12276-024-01272-5","article-title":"Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology","volume":"56","author":"Thorel","year":"2024","journal-title":"Exp Mol Med"},{"issue":"2","key":"10.1016\/j.slasd.2026.100339_bib0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/2472555220942765","article-title":"Hit discovery for public target programs in the European lead factory: experiences and output from assay development and ultra-high-throughput screening","volume":"26","author":"Honarnejad","year":"2021","journal-title":"SLAS Discov"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0006","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41698-021-00168-1","article-title":"Patient-derived organoids as a predictive biomarker for treatment response in cancer patients","volume":"5","author":"Wensink","year":"2021","journal-title":"Npj Precis Oncol"},{"issue":"10","key":"10.1016\/j.slasd.2026.100339_bib0007","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: model systems for human biology and medicine","volume":"21","author":"Kim","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.slasd.2026.100339_bib0008","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","article-title":"Long-term expansion of epithelial organoids from Human colon, adenoma, adenocarcinoma, and Barrett\u2019s epithelium","volume":"141","author":"Sato","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0009","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph0904s44","article-title":"Overview of high-throughput screening","volume":"44","author":"Entzeroth","year":"2009","journal-title":"Curr Protoc Pharmacol"},{"issue":"6","key":"10.1016\/j.slasd.2026.100339_bib0010","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/1087057108319644","article-title":"The future of high-throughput screening","volume":"13","author":"Mayr","year":"2008","journal-title":"SLAS Discov"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0011","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41420-025-02505-w","article-title":"Breakthroughs and challenges of organoid models for assessing cancer immunotherapy: a cutting-edge tool for advancing personalised treatments","volume":"11","author":"Wang","year":"2025","journal-title":"Cell Death Discov"},{"issue":"9","key":"10.1016\/j.slasd.2026.100339_bib0012","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.medj.2021.08.005","article-title":"Promises and challenges of organoid-guided precision medicine","volume":"2","author":"Bose","year":"2021","journal-title":"Med"},{"key":"10.1016\/j.slasd.2026.100339_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.740574","article-title":"Research progress, challenges, and breakthroughs of organoids as disease models","volume":"9","author":"Huang","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"10.1016\/j.slasd.2026.100339_bib0014","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.slasd.2026.100339_bib0015","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ncb3312","article-title":"Organoids as an in vitro model of human development and disease","volume":"18","author":"Fatehullah","year":"2016","journal-title":"Nat Cell Biol"},{"issue":"11","key":"10.1016\/j.slasd.2026.100339_bib0016","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41576-018-0051-9","article-title":"Progress and potential in organoid research","volume":"19","author":"Rossi","year":"2018","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.slasd.2026.100339_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fceng.2023.1120348","article-title":"Organoids in high-throughput and high-content screenings","volume":"5","author":"Lampart","year":"2023","journal-title":"Front Chem Eng"},{"issue":"6","key":"10.1016\/j.slasd.2026.100339_bib0018","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/2472555218766842","article-title":"Advanced development of primary pancreatic organoid tumor models for high-throughput phenotypic drug screening","volume":"23","author":"Hou","year":"2018","journal-title":"SLAS Discov"},{"issue":"4","key":"10.1016\/j.slasd.2026.100339_bib0019","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/2472630319854337","article-title":"Automating a magnetic 3D spheroid model technology for high-throughput screening","volume":"24","author":"Baillargeon","year":"2019","journal-title":"SLAS Technol"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13287-022-02902-3","article-title":"Assay establishment and validation of a high-throughput organoid-based drug screening platform","volume":"13","author":"Li","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"10.1016\/j.slasd.2026.100339_bib0021","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/24725552211020668","article-title":"High-throughput imaging assay for drug screening of 3D prostate cancer organoids","volume":"26","author":"Choo","year":"2021","journal-title":"SLAS Discov"},{"issue":"3","key":"10.1016\/j.slasd.2026.100339_bib0022","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1053\/j.gastro.2020.10.002","article-title":"High-fidelity drug-induced liver injury screen using Human pluripotent stem cell\u2013Derived organoids","volume":"160","author":"Shinozawa","year":"2021","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.slasd.2026.100339_bib0023","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.slasd.2022.03.002","article-title":"Lead identification using 3D models of pancreatic cancer","volume":"27","author":"Fernandez-Vega","year":"2022","journal-title":"SLAS Discov"},{"issue":"8","key":"10.1016\/j.slasd.2026.100339_bib0024","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/jmcb\/mjaa036","article-title":"Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening. Yao X, editor","volume":"12","author":"Du","year":"2020","journal-title":"J Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0025","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12916-023-03034-y","article-title":"Establishment of a large-scale patient-derived high-risk colorectal adenoma organoid biobank for high-throughput and high-content drug screening","volume":"21","author":"Luo","year":"2023","journal-title":"BMC Med"},{"issue":"4","key":"10.1016\/j.slasd.2026.100339_bib0026","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/procel\/pwad038","article-title":"Drug repurposing screening and mechanism analysis based on human colorectal cancer organoids","volume":"15","author":"Mao","year":"2024","journal-title":"Protein Cell"},{"issue":"4","key":"10.1016\/j.slasd.2026.100339_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112324","article-title":"Drug-repurposing screen on patient-derived organoids identifies therapy-induced vulnerability in KRAS-mutant colon cancer","volume":"42","author":"Mertens","year":"2023","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0028","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s42003-019-0305-x","article-title":"A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids","volume":"2","author":"Phan","year":"2019","journal-title":"Commun Biol"},{"issue":"6","key":"10.1016\/j.slasd.2026.100339_bib0029","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1158\/2767-9764.CRC-25-0024","article-title":"High-throughput drug screening of clear cell ovarian cancer organoids reveals vulnerability to proteasome inhibitors and dinaciclib and identifies AGR2 as a therapeutic target","volume":"5","author":"Yoshimura","year":"2025","journal-title":"Cancer Res Commun"},{"issue":"4","key":"10.1016\/j.slasd.2026.100339_bib0030","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1053\/j.gastro.2017.10.043","article-title":"MIR21 Drives resistance to heat shock protein 90 inhibition in cholangiocarcinoma","volume":"154","author":"Lampis","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.slasd.2026.100339_bib0031","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121490","article-title":"Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity","volume":"4","author":"Li","year":"2019","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0032","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.678","article-title":"Patient-derived organoids for personalized gallbladder cancer modelling and drug screening","volume":"12","author":"Yuan","year":"2022","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.slasd.2026.100339_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115275","article-title":"Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine","volume":"218","author":"Langenberg","year":"2025","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.slasd.2026.100339_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2024.01.002","article-title":"Protocol for high throughput 3D drug screening of patient derived melanoma and renal cell carcinoma","volume":"29","author":"Ortiz Jordan","year":"2024","journal-title":"SLAS Discov"},{"issue":"2","key":"10.1016\/j.slasd.2026.100339_bib0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.slasd.2023.01.005","article-title":"Protocol for 3D screening of lung cancer spheroids using natural products","volume":"28","author":"Vega","year":"2023","journal-title":"SLAS Discov"},{"key":"10.1016\/j.slasd.2026.100339_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2024.100201","article-title":"Miniaturization and characterization of patient derived hepatocellular carcinoma tumor organoid cultures for cancer drug discovery applications","volume":"30","author":"Close","year":"2025","journal-title":"SLAS Discov"},{"issue":"7","key":"10.1016\/j.slasd.2026.100339_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2024.100182","article-title":"Development of an automated 3D high content cell screening platform for organoid phenotyping","volume":"29","author":"Bozal","year":"2024","journal-title":"SLAS Discov"},{"issue":"1\u20132","key":"10.1016\/j.slasd.2026.100339_bib0038","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","article-title":"A living biobank of breast cancer organoids captures disease heterogeneity","volume":"172","author":"Sachs","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.slasd.2026.100339_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1190637","article-title":"Patient-derived organoids as a platform for drug screening in metastatic colorectal cancer","volume":"11","author":"He","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"issue":"10","key":"10.1016\/j.slasd.2026.100339_bib0040","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1038\/s41596-020-0379-4","article-title":"Establishment of patient-derived cancer organoids for drug-screening applications","volume":"15","author":"Driehuis","year":"2020","journal-title":"Nat Protoc"},{"issue":"9","key":"10.1016\/j.slasd.2026.100339_bib0041","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.stem.2025.07.008","article-title":"A pancreatic cancer organoid biobank links multi-omics signatures to therapeutic response and clinical evaluation of statin combination therapy","volume":"32","author":"Li","year":"2025","journal-title":"Cell Stem Cell"},{"issue":"8","key":"10.1016\/j.slasd.2026.100339_bib0042","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1177\/2472555218764623","article-title":"Spontaneous glioblastoma spheroid infiltration of early-stage cerebral organoids models brain tumor invasion","volume":"23","author":"Da Silva","year":"2018","journal-title":"SLAS Discov"},{"issue":"13","key":"10.1016\/j.slasd.2026.100339_bib0043","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.3390\/cancers15133289","article-title":"In vitro and In vivo drug-response profiling using patient-derived high-grade glioma","volume":"15","author":"Rajan","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.slasd.2026.100339_bib0044","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.stem.2018.04.022","article-title":"High-throughput screening enhances kidney organoid differentiation from Human pluripotent stem cells and enables automated multidimensional phenotyping","volume":"22","author":"Czerniecki","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13046-023-02608-1","article-title":"Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids","volume":"42","author":"Srimongkol","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.slasd.2026.100339_bib0046","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nbt.3906","article-title":"Guided self-organization and cortical plate formation in human brain organoids","volume":"35","author":"Lancaster","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.slasd.2026.100339_bib0047","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52904","article-title":"A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids","volume":"9","author":"Renner","year":"2020","journal-title":"eLife"},{"issue":"6","key":"10.1016\/j.slasd.2026.100339_bib0048","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.stem.2019.03.009","article-title":"Drug screening in Human PSC-cardiac organoids identifies pro-proliferative compounds acting via the mevalonate pathway","volume":"24","author":"Mills","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0049","doi-asserted-by":"crossref","first-page":"8883","DOI":"10.1038\/srep08883","article-title":"Human iPSC-based cardiac microphysiological system for drug screening applications","volume":"5","author":"Mathur","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0050","doi-asserted-by":"crossref","DOI":"10.1038\/srep24726","article-title":"Miniaturized iPS-cell-derived cardiac muscles for physiologically relevant drug response analyses","volume":"6","author":"Huebsch","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.slasd.2026.100339_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.11.026","article-title":"Novel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro","volume":"78","author":"Leite","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.slasd.2026.100339_bib0052","first-page":"151","article-title":"Magnetic bioassembly platforms towards the generation of extracellular vesicles from human salivary gland functional organoids for epithelial repair","volume":"18","author":"Chansaenroj","year":"2022","journal-title":"Bioact Mater"},{"issue":"3","key":"10.1016\/j.slasd.2026.100339_bib0053","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jcf.2023.03.004","article-title":"FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes","volume":"22","author":"De Poel","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1016\/j.slasd.2026.100339_bib0054","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.stem.2026.06.002","article-title":"Patient-derived organoids reveal ductal dysfunction and CFTR-modulator responses in chronic pancreatitis","volume":"33","author":"Osorio-Vasquez","year":"2026","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.slasd.2026.100339_bib0055","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3390\/cancers13040874","article-title":"Organoid and spheroid tumor models: techniques and applications","volume":"13","author":"Gunti","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.slasd.2026.100339_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1058970","article-title":"Primary human organoids models: current progress and key milestones","volume":"11","author":"Cal\u00e0","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"issue":"9","key":"10.1016\/j.slasd.2026.100339_bib0057","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","article-title":"Organoid profiling identifies common responders to chemotherapy in pancreatic cancer","volume":"8","author":"Tiriac","year":"2018","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101218","article-title":"Protocol for serial organoid formation assay using primary colorectal cancer tissues to evaluate cancer stem cell activity","volume":"3","author":"Bergin","year":"2022","journal-title":"STAR Protoc"},{"issue":"7574","key":"10.1016\/j.slasd.2026.100339_bib0059","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature15695","article-title":"Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis","volume":"526","author":"Takasato","year":"2015","journal-title":"Nature"},{"issue":"7332","key":"10.1016\/j.slasd.2026.100339_bib0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature09691","article-title":"Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro","volume":"470","author":"Spence","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.slasd.2026.100339_bib0061","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.slasd.2026.100339_bib0062","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.stem.2013.12.007","article-title":"Efficient endoderm induction from Human pluripotent stem cells by logically directing signals controlling lineage bifurcations","volume":"14","author":"Loh","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.1016\/j.slasd.2026.100339_bib0063","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/nbt.3392","article-title":"Nephron organoids derived from human pluripotent stem cells model kidney development and injury","volume":"33","author":"Morizane","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"9","key":"10.1016\/j.slasd.2026.100339_bib0064","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1177\/1087057116650965","article-title":"Assay establishment and validation of a high-throughput screening platform for three-dimensional patient-derived colon cancer organoid cultures","volume":"21","author":"Boehnke","year":"2016","journal-title":"SLAS Discov"},{"issue":"9","key":"10.1016\/j.slasd.2026.100339_bib0065","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/pmic.200900758","article-title":"Matrigel: a complex protein mixture required for optimal growth of cell culture","volume":"10","author":"Hughes","year":"2010","journal-title":"PROTEOMICS"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0066","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12929-024-01086-7","article-title":"Enhancing organoid culture: harnessing the potential of decellularized extracellular matrix hydrogels for mimicking microenvironments","volume":"31","author":"Li","year":"2024","journal-title":"J Biomed Sci"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0067","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.172419","article-title":"The effect of extracellular matrix on the precision medicine utility of pancreatic cancer patient\u2013derived organoids","volume":"9","author":"Lumibao","year":"2024","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.slasd.2026.100339_bib0068","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s12079-021-00643-1","article-title":"Matrigel: history\/background, uses, and future applications","volume":"16","author":"Passaniti","year":"2022","journal-title":"J Cell Commun Signal"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0069","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202400322","article-title":"Exploiting the potential of decellularized extracellular matrix (ECM) in tissue engineering: a review study","volume":"25","author":"Brouki Milan","year":"2025","journal-title":"Macromol Biosci"},{"issue":"7","key":"10.1016\/j.slasd.2026.100339_bib0070","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41578-020-0199-8","article-title":"Synthetic alternatives to Matrigel","volume":"5","author":"Aisenbrey","year":"2020","journal-title":"Nat Rev Mater"},{"issue":"7","key":"10.1016\/j.slasd.2026.100339_bib0071","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1021\/acsbiomaterials.6b00506","article-title":"Overview of the development, applications, and future perspectives of decellularized tissues and organs","volume":"3","author":"Nakamura","year":"2017","journal-title":"ACS Biomater Sci Eng"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0072","doi-asserted-by":"crossref","DOI":"10.1038\/srep13987","article-title":"A spheroid toxicity assay using magnetic 3D bioprinting and real-time mobile device-based imaging","volume":"5","author":"Tseng","year":"2015","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.slasd.2026.100339_bib0073","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.slasd.2021.11.002","article-title":"Development of high-throughput lacrimal gland organoid platforms for drug discovery in dry eye disease","volume":"27","author":"Rodboon","year":"2022","journal-title":"SLAS Discov"},{"issue":"2","key":"10.1016\/j.slasd.2026.100339_bib0074","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3390\/ijms24021006","article-title":"An automated high-throughput screening (HTS) spotter for 3D tumor spheroid formation","volume":"24","author":"Jeong","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40360-025-01074-z","article-title":"A human liver organoids-on-chip for the assessment of drug-induced liver injury","volume":"27","author":"Chen","year":"2026","journal-title":"BMC Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.slasd.2026.100339_bib0076","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1053\/j.gastro.2020.06.010","article-title":"Human pluripotent stem cell-derived organoids as models of liver disease","volume":"159","author":"Ramli","year":"2020","journal-title":"Gastroenterology"},{"issue":"15","key":"10.1016\/j.slasd.2026.100339_bib0077","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1073\/pnas.1015938108","article-title":"Retaining cell\u2013cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer","volume":"108","author":"Kondo","year":"2011","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"10.1016\/j.slasd.2026.100339_bib0078","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1039\/D4LC00149D","article-title":"Reproducible generation of human liver organoids (HLOs) on a pillar plate platform via microarray 3D bioprinting","volume":"24","author":"Shrestha","year":"2024","journal-title":"Lab Chip"},{"issue":"2","key":"10.1016\/j.slasd.2026.100339_bib0079","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1039\/D4LC00459K","article-title":"An agarose fluidic chip for high-throughput in toto organoid imaging","volume":"25","author":"De Beuckeleer","year":"2025","journal-title":"Lab Chip"},{"issue":"12","key":"10.1016\/j.slasd.2026.100339_bib0080","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1021\/acsptsci.4c00565","article-title":"A high-throughput and logarithm-serial-dilution microfluidic chip for combinational drug screening on tumor organoids","volume":"7","author":"Yan","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.slasd.2026.100339_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.talo.2025.100531","article-title":"High-throughput microfluidic generation of self-assembled, uniform 3D vascularized and mineralized bone organoids without matrix biomaterials","volume":"12","author":"Li","year":"2025","journal-title":"Talanta Open"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0082","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1038\/s41467-020-19058-4","article-title":"Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids","volume":"11","author":"Schuster","year":"2020","journal-title":"Nat Commun"},{"issue":"17","key":"10.1016\/j.slasd.2026.100339_bib0083","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1039\/C9LC00496C","article-title":"A one-stop microfluidic-based lung cancer organoid culture platform for testing drug sensitivity","volume":"19","author":"Jung","year":"2019","journal-title":"Lab Chip"},{"issue":"10","key":"10.1016\/j.slasd.2026.100339_bib0084","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1021\/acsbiomaterials.0c00682","article-title":"Modeling Human nonalcoholic fatty liver disease (NAFLD) with an organoids-on-a-chip system","volume":"6","author":"Wang","year":"2020","journal-title":"ACS Biomater Sci Eng"},{"issue":"10","key":"10.1016\/j.slasd.2026.100339_bib0085","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1039\/D5LC00154D","article-title":"A high-throughput microfluidic platform for functional hiPSC-derived liver organoids with bile duct- and lobule-like structures","volume":"25","author":"Zhang","year":"2025","journal-title":"Lab Chip"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0086","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12967-024-05986-y","article-title":"Heart-on-a-chip: a revolutionary organ-on-chip platform for cardiovascular disease modeling","volume":"23","author":"Liu","year":"2025","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.slasd.2026.100339_bib0087","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nprot.2016.006","article-title":"Organoid culture systems for prostate epithelial and cancer tissue","volume":"11","author":"Drost","year":"2016","journal-title":"Nat Protoc"},{"issue":"7","key":"10.1016\/j.slasd.2026.100339_bib0088","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/2472555220915827","article-title":"Comparison of cell and organoid-level analysis of patient-derived 3D organoids to evaluate tumor cell growth dynamics and drug response","volume":"25","author":"Kim","year":"2020","journal-title":"SLAS Discov"},{"issue":"3","key":"10.1016\/j.slasd.2026.100339_bib0089","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.slasd.2022.03.004","article-title":"deepOrganoid: a brightfield cell viability model for screening matrix-embedded organoids","volume":"27","author":"Powell","year":"2022","journal-title":"SLAS Discov"},{"key":"10.1016\/j.slasd.2026.100339_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2025.100218","article-title":"Optimized scaffold-free human 3D adipose tissue organoid culture for obesity and disease modeling","volume":"31","author":"Dariolli","year":"2025","journal-title":"SLAS Discov"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0091","doi-asserted-by":"crossref","DOI":"10.1002\/cpim.106","article-title":"Establishment and culture of Human intestinal organoids derived from adult stem cells","volume":"130","author":"Pleguezuelos-Manzano","year":"2020","journal-title":"Curr Protoc Immunol"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0092","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1038\/s41467-021-25329-5","article-title":"Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease","volume":"12","author":"Lewis-Israeli","year":"2021","journal-title":"Nat Commun"},{"issue":"15","key":"10.1016\/j.slasd.2026.100339_bib0093","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1364\/OL.493824","article-title":"Dual-modality imaging system for monitoring human heart organoids beating in vitro","volume":"48","author":"Hao","year":"2023","journal-title":"Opt Lett"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0094","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1038\/s41598-025-34504-3","article-title":"Non-invasive electrophysiological monitoring of cardiac organoids using 3D-net-assisted microelectrodes array platform","volume":"16","author":"Park","year":"2026","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0095","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41377-020-00375-8","article-title":"Dynamic full-field optical coherence tomography: 3D live-imaging of retinal organoids","volume":"9","author":"Scholler","year":"2020","journal-title":"Light Sci Appl"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0096","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1038\/s41467-022-32465-z","article-title":"Multiscale light-sheet organoid imaging framework","volume":"13","author":"De Medeiros","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.slasd.2026.100339_bib0097","first-page":"140","article-title":"Harnessing the power of artificial intelligence for human living organoid research","volume":"42","author":"Wang","year":"2024","journal-title":"Bioact Mater"},{"issue":"11","key":"10.1016\/j.slasd.2026.100339_bib0098","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3390\/bioengineering12111216","article-title":"Enhanced U-net-based deep learning model for automated segmentation of organoid images","volume":"12","author":"Alani","year":"2025","journal-title":"Bioengineering"},{"issue":"6","key":"10.1016\/j.slasd.2026.100339_bib0099","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/s41592-025-02685-4","article-title":"Digitalized organoids: integrated pipeline for high-speed 3D analysis of organoid structures using multilevel segmentation and cellular topology","volume":"22","author":"Ong","year":"2025","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48874-y","article-title":"OrgaQuant: human intestinal organoid localization and quantification using deep convolutional neural networks","volume":"9","author":"Kassis","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.slasd.2026.100339_bib0101","doi-asserted-by":"crossref","first-page":"8406","DOI":"10.1038\/s41467-023-44162-6","article-title":"High-throughput deconvolution of 3D organoid dynamics at cellular resolution for cancer pharmacology with Cellos","volume":"14","author":"Mukashyaka","year":"2023","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.slasd.2026.100339_bib0102","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41592-022-01508-0","article-title":"Automated high-speed 3D imaging of organoid cultures with multi-scale phenotypic quantification","volume":"19","author":"Beghin","year":"2022","journal-title":"Nat Methods"},{"issue":"11","key":"10.1016\/j.slasd.2026.100339_bib0103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1010584","article-title":"OrganoID: a versatile deep learning platform for tracking and analysis of single-organoid dynamics","volume":"18","author":"Matthews","year":"2022","journal-title":"PLOS Comput Biol"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0104","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48343-7","article-title":"An AI-based segmentation and analysis pipeline for high-field MR monitoring of cerebral organoids","volume":"13","author":"Deininger","year":"2023","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.slasd.2026.100339_bib0105","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cels.2023.08.002","article-title":"A microwell platform for high-throughput longitudinal phenotyping and selective retrieval of organoids","volume":"14","author":"Sockell","year":"2023","journal-title":"Cell Syst"},{"issue":"513","key":"10.1016\/j.slasd.2026.100339_bib0106","doi-asserted-by":"crossref","first-page":"eaay2574","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.slasd.2026.100339_bib0107","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","article-title":"Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"14","key":"10.1016\/j.slasd.2026.100339_bib0108","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1158\/1078-0432.CCR-20-0073","article-title":"Medium-throughput drug screening of patient-derived organoids from colorectal peritoneal metastases to direct personalized therapy","volume":"26","author":"Narasimhan","year":"2020","journal-title":"Clin Cancer Res"}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555226000456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555226000456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:04:09Z","timestamp":1794207849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555226000456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":108,"alternative-id":["S2472555226000456"],"URL":"https:\/\/doi.org\/10.1016\/j.slasd.2026.100339","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-derived 3d cell models as new approach methodologies: Applications, advances, and challenges for increased-throughput assays","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.slasd.2026.100339","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Society for Laboratory Automation and Screening.","name":"copyright","label":"Copyright"}],"article-number":"100339"}}